Synthesis of Gold Nanoparticles with Polyamidoamine (Pamam) Generation 4 Dendrimer as Stabilizing Agent for CT Scan Contrast Agent
Summary
Gold nanoparticles have great potential in biomedical applications as both a therapeutic
and diagnostic agents. Pamam dendrimers are spherical, highly branched macromolecules
with a narrow polydispersity to encapsulate and stabilize metal nanoparticles. In
the preparation of metal nanoparticles, stabilizers play an important role in controlling
particle size. The objectives of this study were to synthesize and characterize of
gold nanoparticles. The gold nanoparticles were prepared by reduction of tetrachloroauric
acid using sodium borohydride with and without addition of pamam generation 4 dendrimer
as stabilizing agent. Gold nanoparticles stabilized pamam generation 4 dendrimer were
characterized by Uv‐Vis spectrometry, transmission electron microscopy (TEM), dynamic
light scattering (DLS) and zetasizer. The result showed that UV–vis absorption spectra
of gold nanoparticles without pamam G4 dendrimer at 530 nm while absorption spectra
of gold–pamam G4 dendrimer at 280 nm. The absorbance peak at 280 nm related to individual
of gold nanoparticle encapsulated pamam dendrimer. TEM analysis exhibits the occurrence
aggregation of gold nanoparticles without pamam G4 dendrimer. DLS analysis exhibit
gold nanoparticles has a particles size 88‐252 nm while gold‐pamam G4 dendrimer nanoparticles
2‐15 nm. The addition of pamam generation 4 dendrimer on preparation of gold nanoparticles
could prevent aggregation of nanoparticles through entrapment in cavity or core molecules.
Au‐PAMAM G4 nanoparticles 0.1 mg/ml has a greater Hounsfield unit (HU) value than
iodine at the same concentration, so it has better contrast properties.
Number of times cited: 2
- Benjamin M. Yeh, Paul F. FitzGerald, Peter M. Edic, Jack W. Lambert, Robert E. Colborn, Michael E. Marino, Paul M. Evans, Jeannette C. Roberts, Zhen J. Wang, Margaret J. Wong and Peter J. Bonitatibus, Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies, Advanced Drug Delivery Reviews, 10.1016/j.addr.2016.09.001, 113, (201-222), (2017).
- Michael Müller, Neha Agarwal and Jungtae Kim, A Cytochrome P450 3A4 Biosensor Based on Generation 4.0 PAMAM Dendrimers for the Detection of Caffeine, Biosensors, 6, 4, (44)




